About Parkinson’s Clinical Trials
Although synthetic L-DOPA is very helpful during the early phase of Parkinson’s Disease, as time goes by its effectiveness as measured by the ‘ON’ time decreases and ‘OFF’ time increases. So, usually after five years of therapy, the off phase cannot be decreased by current medications.
One intriguing possibility is that a new medicine can be added that can make your own dopamine more sensitive and be effective for a longer time? This possibility is being explored by newer research.
The NWCRC is looking for volunteers who may have the problem of long ’OFF’ periods.
To be contacted about this study, fill out the contact form or call 425-453-0404.
Signs and symptoms
- Severe tremors of the limbs and body
- Difficulty in getting to move
- Limbs feel stiff
The Role of a Caregiver
For all of our studies for dementia, a study partner or caregiver is required. The role of a caregiver is vital for evaluating the study medication. They will be attending visits and communicating with study personnel to help the study team monitor symptoms such as memory impairment, functioning at home, and behavior. Without research volunteers and their family and friends, it would not be possible to evaluate if these medications for Parkinson’s Disease maintain functioning as well as the quality of life for patients and caregivers. Compensation for your time and a travel stipend are available to those who qualify and elect to participate.
Duration
- 3 to 4 months
No Cost Study
There is no cost to participate in the study. If they qualify for the study, the participant will receive the following:
- Medical evaluation.
- Investigational Medication.
- Study Related Medical Care.
- Compensation available.
- Complimentary transportation or a travel stipend.
